By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MicuRx Pharmaceuticals 

29540 Kohoutek Way

Union City  California    U.S.A.
Phone: 510-324-8662 Fax: n/a


Company News
MicuRx Pharmaceuticals Says Novel Antibiotic Passes China Phase II Test 9/1/2015 10:04:17 AM
MicuRx Pharmaceuticals Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 8/31/2015 6:21:24 AM
MicuRx Pharmaceuticals Initiates U.S. Phase 2 Clinical Trial For Novel Antibiotic MRX-I 2/25/2015 6:44:38 AM
MicuRx Pharmaceuticals Expands Global Clinical Trial Program For Oral Antibiotic MRX-I 12/20/2013 11:02:53 AM
Week in Review: MicuRx Pharmaceuticals Raises $25 Million for Antibiotic Clinical Trial 8/26/2013 9:02:03 AM
MicuRx Pharmaceuticals Completes $25 Million Series B Financing 8/22/2013 6:43:36 AM
MicuRx Pharmaceuticals Inks $9.6 Million Pact With Shanghai Zhangjiang Biomedical Industry Venture Capital 10/24/2012 7:33:45 AM
MicuRx Pharmaceuticals Announces Issuance of U.S. Patent for Its Next-Generation Antibacterial Agent 5/23/2012 10:40:18 AM
MicuRx Pharmaceuticals Completes Phase 1 Trial For MRX-I, A Next-Generation Antibiotic 4/23/2012 9:52:19 AM
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I - MRX-I Targets Multi-Drug Resistant Gram Positive Infections 3/15/2010 10:30:30 AM